Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 5Active not recruiting 3Enrolling by invitation 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Neoplasms 33Breast Neoplasms 17Prostatic Neoplasms 15Colorectal Neoplasms 13Hematologic Neoplasms 8Precursor Cell Lymphoblastic Leukemia-Lymphoma 6Lung Neoplasms 6Stomach Neoplasms 5Squamous Cell Carcinoma of Head and Neck 5Lymphoma, Non-Hodgkin 5Leukemia, Myeloid, Acute 5Uterine Cervical Neoplasms 4Pancreatic Neoplasms 4Myasthenia Gravis 4Melanoma 4Lymphoma 4Head and Neck Neoplasms 4Carcinoma, Non-Small-Cell Lung 4Adenocarcinoma 4Pain 3Ovarian Neoplasms 3Neoplasm Metastasis 3Leukemia, Lymphocytic, Chronic, B-Cell 3Leukemia 3Hematopoietic and Lymphatic System Neoplasm 3Hematologic Diseases 3Glioma 3Gastrointestinal Neoplasms 3Disease 3Colonic Neoplasms 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Enrolling by invitation × von Hippel-Lindau Disease × 90 days × Clear all
NCT00102544 2026-06-05

Use of Tracking Devices to Locate Abnormalities During Invasive Procedures

National Institutes of Health Clinical Center (CC)

Phase NA Enrolling by invitation
3,894 enrolled
Genitourinary

Adenocarcinoma, Carcinoma, Renal Cell, von Hippel-Lindau Disease, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡